Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3

被引:34
作者
Galanis, M
Firth, SM
Bond, J
Nathanielsz, A
Kortt, AA
Hudson, PJ
Baxter, RC [1 ]
机构
[1] Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia
[2] CRC Diagnost Technol, Parkville, Vic 3052, Australia
[3] CSIRO, Div Hlth Sci & Nutr, Parkville, Vic 3052, Australia
关键词
D O I
10.1677/joe.0.1690123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin-like growth factor-binding protein-3 (IGFBP-3) is a member of a family of structurally conserved proteins (IGFBP-1 to -f,) which act as carriers and regulators of the mitogenic peptide hormones IGF-I and IGF-II. Members of the IGFBP family share conserved cysteine-rich amino-and carboxyl-terminal regions. The amino-terminal domain of these proteins is recognised to contain an IGF-binding. determinant, but evidence to support a binding site ill the carboxyl-terminal region of the protein is less rigorous. To further investigate this,we have synthesised both the amino-terminal (residues 1-88; N-88) and carboxyl-terminal (residues 165-264; C-165) domains of human IGFBP-3 in bacteria, as fusion proteins with a carboxyl-terminal FLAG peptide. Although only C-165 showed binding to IGF-I and -II by solution-binding assays, both N-88 and C-165 demonstrated binding to ICF-I and -II by biosensor analysis albeit with reduced affinities compared with full-length ICFBP-3. Only the carboxyl-terminal fragment (C-165) was able to form hetero-trimeric complexes with IGF-I and the acid-labile subunit (ALS). We conclude that the carbosyl-terminal domain of IGEBP-3 contains an IGF-binding determinant and can form ternary complexes with ALS.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 40 条
[1]  
BACH LA, 1993, ADV EXP MED BIOL, V343, P55
[2]  
BAXTER RC, 1989, J BIOL CHEM, V264, P11843
[3]  
BAXTER RC, 1992, J BIOL CHEM, V267, P60
[4]   RADIOIMMUNOASSAY OF GROWTH-HORMONE DEPENDENT INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN IN HUMAN-PLASMA [J].
BAXTER, RC ;
MARTIN, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1504-1512
[5]  
Baxter RC, 1997, ADV MOL CELL ENDOCRI, V1, P123, DOI DOI 10.1016/S1569-2566(97)80036-1
[6]   MUTATIONS IN THE C-TERMINAL PART OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN-1 RESULT IN DIMER FORMATION AND LOSS OF IGF BINDING-CAPACITY [J].
BRINKMAN, A ;
KORTLEVE, DJ ;
ZWARTHOFF, EC ;
DROP, SLS .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (07) :987-994
[7]   SITE-DIRECTED MUTAGENESIS OF THE N-TERMINAL REGION OF IGF BINDING PROTEIN-1 - ANALYSIS OF IGF BINDING CAPABILITY [J].
BRINKMAN, A ;
KORTLEVE, DJ ;
SCHULLER, AGP ;
ZWARTHOFF, EC ;
DROP, SLS .
FEBS LETTERS, 1991, 291 (02) :264-268
[8]   Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3 [J].
Dubaquié, Y ;
Lowman, HB .
BIOCHEMISTRY, 1999, 38 (20) :6386-6396
[9]   Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3 [J].
Firth, SM ;
Ganeshprasad, U ;
Baxter, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2631-2638
[10]   Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3 [J].
Firth, SM ;
Baxter, RC .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (03) :379-387